Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
0.620
-0.017 (-2.65%)
Apr 29, 2026, 11:58 AM EDT - Market open
Silexion Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2013 | FY 2012 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
| Market Capitalization | 2 | 6 | 3 | 42 | - | - |
| Market Cap Growth | -70.95% | 86.31% | -92.33% | - | - | - |
| Enterprise Value | -2 | -1 | 6 | 41 | - | - |
| Last Close Price | 0.64 | 1.92 | 30.15 | 1464.75 | - | - |
| PB Ratio | 0.77 | 2.31 | -0.81 | 13.99 | - | - |
| P/TBV Ratio | 0.82 | 2.31 | - | - | - | - |
| Debt / Equity Ratio | 0.78 | 0.78 | -1.13 | 0.06 | - | - |
| Net Debt / Equity Ratio | -1.52 | -1.52 | -0.83 | -1.47 | -1.13 | -0.98 |
| Net Debt / EBITDA Ratio | 0.34 | 0.34 | -0.26 | 0.95 | 0.58 | 1.68 |
| Net Debt / FCF Ratio | 0.37 | 0.37 | -0.39 | 0.97 | 0.99 | 1.75 |
| Quick Ratio | 2.17 | 2.17 | 0.34 | 2.09 | 3.64 | 10.47 |
| Current Ratio | 2.41 | 2.41 | 0.64 | 2.27 | 3.85 | 10.64 |
| Return on Equity (ROE) | - | - | - | - | -116.66% | - |
| Return on Assets (ROA) | -144.28% | -144.28% | -193.54% | - | -62.13% | - |
| Return on Capital Employed (ROCE) | -261.00% | -261.00% | 1904.70% | -153.00% | -195.10% | -58.60% |
| Earnings Yield | -561.43% | -198.43% | -510.30% | -11.77% | - | - |
| FCF Yield | -510.34% | -180.37% | -261.25% | -10.81% | - | - |
| Buyback Yield / Dilution | -7975.28% | -3093.26% | - | - | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.